Erin Parsons serves as Executive at KIORA PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Erin Parsons has executed 1 insider transactions totaling $25.7K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 13, 2024 involved purchasing 5,260 shares valued at $25.7K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jun 13, 2024 | KPRX | $25.7K | Purchase | 5,260 | $4.88 | Discretionary |
Erin Parsons currently holds 5,260 shares of KIORA PHARMACEUTICALS INC (KPRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Erin Parsons has been a net buyer of KPRX stock. They have purchased $25.7K and sold $0 worth of shares.
Erin Parsons's most recent insider trade was on Jun 13, 2024, when they purchased 5,260 shares at $4.88 per share.
Get notified when new Form 4 filings are submitted